Trial Profile
A phase I single and multiple dose study of NP03 for the treatment of Huntington's disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 May 2016
Price :
$35
*
At a glance
- Drugs Lithium citrate (Primary)
- Indications Huntington's disease
- Focus Adverse reactions; Pharmacokinetics
- 14 May 2016 New trial record